These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6449827)

  • 21. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
    Oyekan AO; McAward K; Conetta J; Rosenfeld L; McGiff JC
    Am J Physiol; 1999 Mar; 276(3):R766-75. PubMed ID: 10070137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ouabain as an amplifier of mineralocorticoid-induced hypertension.
    Sekihara H; Yazaki Y; Kojima T
    Endocrinology; 1992 Dec; 131(6):3077-82. PubMed ID: 1446641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension.
    Hartner A; Klanke B; Cordasic N; Amann K; Schmieder RE; Veelken R; Hilgers KF
    J Hypertens; 2009 Feb; 27(2):376-85. PubMed ID: 19226708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dietary calcium on the development of hypertension and hypertensive vascular lesions in DOCA-salt and two-kidney, one clip hypertensive rats.
    Liu DT; Birchall I; Hewitson T; Kincaid-Smith P; Whitworth JA
    J Hypertens; 1994 Feb; 12(2):145-53. PubMed ID: 8021465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased vasopressinergic activity following DOCA administration in the rat.
    Chen YF; Lindheimer MD; Oparil S
    Brain Res Bull; 1986 Jan; 16(1):93-8. PubMed ID: 3955390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertensinogenic factors and renal alpha-adrenoceptors in young SHR and WKY rats.
    Sáiz J; Lara B; Torres A; Sánchez A
    Life Sci; 1987 Nov; 41(20):2261-8. PubMed ID: 2824946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
    Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
    Circulation; 2000 Nov; 102(22):2765-73. PubMed ID: 11094045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
    Theriot JA; Passmore JC; Jimenez AE; Fleming JT
    J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary suppression of prostaglandin synthesis does not accelerate DOCA/salt hypertension in rats.
    Codde JP; Croft KD; Beilin LJ
    Clin Exp Pharmacol Physiol; 1987 Jun; 14(6):513-23. PubMed ID: 3315335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains.
    Erdely A; Freshour G; Tain YL; Engels K; Baylis C
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F192-6. PubMed ID: 16896184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.